Cite Filings / IRD / 0001193125-26-052859
Feed Companies Filings Check
Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Opus Genetics, Inc. · Filed 2026-02-17 · Acc 0001193125-26-052859

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-05-13 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-02-19 8-K Material agreement · Results of operations · Unregistered share sale · Bylaws or fiscal year change · Other events
  • 2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-02-17 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-02-17 4 Chief Scientific & Dev. Ofc. gave up 5,313 shares (to pay taxes)
  • 2026-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-11 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Caligan Partners LP 6.2%
  2. 2026-11-16 SCHEDULE 13G · Boxer Capital Management, LLC 5.4%
  3. 2026-11-16 SCHEDULE 13G · Cormorant Asset Management, LP 6.61%
  4. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 7.36%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…